Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection.
about
The physiological action of picolinic Acid in the human brainCellular interplay between neurons and glia: toward a comprehensive mechanism for excitotoxic neuronal loss in neurodegenerationQuinolinic acid selectively induces apoptosis of human astrocytes: potential role in AIDS dementia complex.Neuropsychological Dysfunction among HIV Infected Drug AbusersGenetic variation and HIV-associated neurologic disease.Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline.The kynurenine pathway and quinolinic acid: pivotal roles in HIV associated neurocognitive disorders.Regulation of indoleamine 2,3-dioxygenase expression in simian immunodeficiency virus-infected monkey brains.HIV, dementia and antiretroviral drugs: 30 years of an epidemic.HIV-1 Tat protein induces the production of IDO in human monocyte derived-dendritic cells through a direct mechanism: effect on T cells proliferation.Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS.HIV-1 Tat activates indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures in a p38 mitogen-activated protein kinase-dependent manner.The role of the kynurenine pathway in suicidality in adolescent major depressive disorder.Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS.Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitisRho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE)Low-dose aspirin (acetylsalicylate) prevents increases in brain PGE2, 15-epi-lipoxin A4 and 8-isoprostane concentrations in 9 month-old HIV-1 transgenic rats, a model for HIV-1 associated neurocognitive disorders.Regional cortical thinning associated with detectable levels of HIV DNA.Neuropathologic contributions to understanding AIDS and the central nervous system.The possible role of the kynurenine pathway in anhedonia in adolescents.Current understanding of HIV-associated neurocognitive disorders pathogenesis.NeuroAIDS: characteristics and diagnosis of the neurological complications of AIDS.Neuromodulatory activities of CD4+CD25+ regulatory T cells in a murine model of HIV-1-associated neurodegeneration.Mapping cerebellar degeneration in HIV/AIDSProbiotics Differently Affect Gut-Associated Lymphoid Tissue Indolamine-2,3-Dioxygenase mRNA and Cerebrospinal Fluid Neopterin Levels in Antiretroviral-Treated HIV-1 Infected Patients: A Pilot Study.CNS inflammation and macrophage/microglial biology associated with HIV-1 infection.The Janus-faced nature of IDO1 in infectious diseases: challenges and therapeutic opportunities.Fate of microglia during HIV-1 infection: From activation to senescence?Major developments in the design of inhibitors along the kynurenine pathway.Motor-related brain abnormalities in HIV-infected patients: a multimodal MRI study.Characterisation of the kynurenine pathway in skin-derived fibroblasts and keratinocytes.Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease.Is the Enzyme ACMSD a Novel Therapeutic Target in Parkinson's Disease?Disruption of excitatory amino acid transporters in brains of SIV-infected rhesus macaques is associated with microglia activation.The impact of neuropsychological functioning and depressed mood on functional complaints in HIV-1 infection and methamphetamine dependence.Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: a novel pharmacological action of memantine.Cognitive impairment in HIV infection is associated with MRI and CSF pattern of neurodegeneration.A putative urinary biosignature for diagnosis and follow-up of tuberculous meningitis in children: outcome of a metabolomics study disclosing host–pathogen responses
P2860
Q24634995-7906D585-82C6-426A-A378-2EE390E70706Q24654460-021CCB8D-72BB-41A5-AA36-53AF39383439Q24814135-52A7E439-CABB-4803-99A3-C48CB94F2EF3Q30389107-15CF9D45-7935-4216-BDC6-E2EE69312C34Q33819189-9C89B732-62D5-42C5-B24F-88E73F6BBC2FQ34098327-7D70F1F8-04D5-4624-BDED-E0FFE2E0BC5BQ34248380-37BFFB3D-47D3-4D1F-A687-F582D19B6517Q34359001-F3653C92-9FA8-498C-9038-CEE5C18F7390Q34573511-F347FDE0-78B1-472E-8D3B-535E7842051DQ35000687-D37A6104-50F9-4405-8FE5-9C1A61BC1E93Q35177355-E504FCFE-B95E-4C19-BFB5-EA135DD24D5BQ35183177-E2D63FAD-9822-48D2-A1B7-AB32D0C19BDDQ35602606-EF114C69-4752-42A7-BA1A-33EB750CFFE9Q35791409-DE9106BA-651D-4067-9C57-41E4B7C6BC92Q35848218-D6E9E07C-562C-4E8F-8856-894B927D8651Q35849738-B4EC9794-B8F7-44F0-A4A5-BB22F9828722Q36035835-2E822BA4-DEC6-4DDC-8C01-2A8AC055A43BQ36142331-D575D4FF-3140-4944-B85D-19AF4A50B50BQ36771870-A3067A04-FBA1-44D1-8D8D-D85ED9BACA50Q36921329-28BAB96F-B077-4E19-96AD-A266FBC56E41Q36932005-17A1F171-006C-45CD-BB66-BA696D5C6D99Q37089861-2F132920-5546-42C8-9CFB-66AD49128657Q37141166-2E06D44F-A89C-4D29-BE6B-A38E265B2D52Q37268035-705A52B2-A007-448E-95B3-00F978D2F5D6Q37377261-2E2EB7E9-9681-4146-B253-530FF6C4C97BQ37600700-E8F09007-82EF-49DE-BEE1-41FBDA6F2CF2Q38675915-8FDF05D1-E1BD-44BB-B90A-FAA1CCF533A8Q38790617-4D8B5785-0131-446B-A06E-1A5AF1AD4A5AQ38808400-2A9F2CD8-0A9A-4213-A335-AAEAC4BAF553Q40058778-90AB0D28-3E70-4A18-9BB0-46B553360128Q41499706-DFB70194-ED0C-4475-B38A-5BF205CB6CEEQ42948425-F0A36AA1-D0D3-4F2D-86A7-15D21513395AQ43721606-9601C4A4-55F9-4973-A8E3-B77073B66DEAQ45238729-6F807F86-D22A-4159-A432-5C6E45C77421Q46191423-CAF5EDF8-4F9C-4470-9F79-9A74807BD7E3Q46922833-70A5AAA7-282D-4ED3-B43E-70BA65BFF05AQ48323194-4DAF7315-FB3F-4F77-AC83-2CAB4632CB55Q57719311-308D7D81-A3B2-4243-9198-52D481BBD69E
P2860
Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Elevated cerebrospinal fluid q ...... volume loss in HIV infection.
@en
Elevated cerebrospinal fluid q ...... volume loss in HIV infection.
@nl
type
label
Elevated cerebrospinal fluid q ...... volume loss in HIV infection.
@en
Elevated cerebrospinal fluid q ...... volume loss in HIV infection.
@nl
prefLabel
Elevated cerebrospinal fluid q ...... volume loss in HIV infection.
@en
Elevated cerebrospinal fluid q ...... volume loss in HIV infection.
@nl
P2093
P356
P1433
P1476
Elevated cerebrospinal fluid q ...... volume loss in HIV infection.
@en
P2093
HNRC Group. HIV Neurobehavioral Research Center
M E Childers
S Archibald
T L Jernigan
P304
P356
10.1093/BRAIN/124.5.1033
P407
P577
2001-05-01T00:00:00Z